Teladoc Health Inc (TDOC) concluded trading on Thursday at a closing price of $7.25, with 5.26 million shares of worth about $38.13 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.10% during that period and on May 15, 2025 the price saw a loss of about -1.23%. Currently the company’s common shares owned by public are about 175.34M shares, out of which, 172.09M shares are available for trading.
Stock saw a price change of 2.40% in past 5 days and over the past one month there was a price change of 1.54%. Year-to-date (YTD), TDOC shares are showing a performance of -20.24% which decreased to -41.77% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.35 but also hit the highest price of $15.21 during that period. The average intraday trading volume for Teladoc Health Inc shares is 7.22 million. The stock is currently trading 2.08% above its 20-day simple moving average (SMA20), while that difference is down -6.08% for SMA50 and it goes to -19.36% lower than SMA200.
Teladoc Health Inc (NYSE: TDOC) currently have 175.34M outstanding shares and institutions hold larger chunk of about 73.80% of that.
The stock has a current market capitalization of $1.27B and its 3Y-monthly beta is at 1.81. It has posted earnings per share of -$5.93 in the same period. It has Quick Ratio of 1.61 while making debt-to-equity ratio of 1.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TDOC, volatility over the week remained 4.30% while standing at 5.03% over the month.
Stock’s fiscal year EPS is expected to rise by 81.21% while it is estimated to increase by 22.66% in next year. EPS is likely to grow at an annualized rate of 46.21% for next 5-years, compared to annual growth of -33.66% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on November 15, 2024 offering a Buy rating for the stock and assigned a target price of $14 to it. Coverage by Jefferies stated Teladoc Health Inc (TDOC) stock as a Hold in their note to investors on September 17, 2024, suggesting a price target of $10 for the stock. On February 29, 2024, Cantor Fitzgerald Initiated their recommendations, while on February 26, 2024, Leerink Partners Initiated their ratings for the stock with a price target of $17. Stock get a Neutral rating from DA Davidson on January 17, 2024.
